Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
08
2021
accepted:
19
11
2021
entrez:
17
12
2021
pubmed:
18
12
2021
medline:
11
1
2022
Statut:
epublish
Résumé
Camps of forcibly displaced populations are considered to be at risk of large COVID-19 outbreaks. Low screening rates and limited surveillance led us to conduct a study in Dagahaley camp, located in the Dadaab refugee complex in Kenya to estimate SARS-COV-2 seroprevalence and, mortality and to identify changes in access to care during the pandemic. To estimate seroprevalence, a cross-sectional survey was conducted among a sample of individuals (n = 587) seeking care at the two main health centres and among all household members (n = 619) of community health workers and traditional birth attendants working in the camp. A rapid immunologic assay was used (BIOSYNEX® COVID-19 BSS [IgG/IgM]) and adjusted for test performance and mismatch between the sampled population and that of the general camp population. To estimate mortality, all households (n = 12860) were exhaustively interviewed in the camp about deaths occurring from January 2019 through March 2021. In total 1206 participants were included in the seroprevalence study, 8% (95% CI: 6.6%-9.7%) had a positive serologic test. After adjusting for test performance and standardizing on age, a seroprevalence of 5.8% was estimated (95% CI: 1.6%-8.4%). The mortality rate for 10,000 persons per day was 0.05 (95% CI 0.05-0.06) prior to the pandemic and 0.07 (95% CI 0.06-0.08) during the pandemic, representing a significant 42% increase (p<0.001). Médecins Sans Frontières health centre consultations and hospital admissions decreased by 38% and 37% respectively. The number of infected people was estimated 67 times higher than the number of reported cases. Participants aged 50 years or more were among the most affected. The mortality survey shows an increase in the mortality rate during the pandemic compared to before the pandemic. A decline in attendance at health facilities was observed and sustained despite the easing of restrictions.
Sections du résumé
BACKGROUND
Camps of forcibly displaced populations are considered to be at risk of large COVID-19 outbreaks. Low screening rates and limited surveillance led us to conduct a study in Dagahaley camp, located in the Dadaab refugee complex in Kenya to estimate SARS-COV-2 seroprevalence and, mortality and to identify changes in access to care during the pandemic.
METHODS
To estimate seroprevalence, a cross-sectional survey was conducted among a sample of individuals (n = 587) seeking care at the two main health centres and among all household members (n = 619) of community health workers and traditional birth attendants working in the camp. A rapid immunologic assay was used (BIOSYNEX® COVID-19 BSS [IgG/IgM]) and adjusted for test performance and mismatch between the sampled population and that of the general camp population. To estimate mortality, all households (n = 12860) were exhaustively interviewed in the camp about deaths occurring from January 2019 through March 2021.
RESULTS
In total 1206 participants were included in the seroprevalence study, 8% (95% CI: 6.6%-9.7%) had a positive serologic test. After adjusting for test performance and standardizing on age, a seroprevalence of 5.8% was estimated (95% CI: 1.6%-8.4%). The mortality rate for 10,000 persons per day was 0.05 (95% CI 0.05-0.06) prior to the pandemic and 0.07 (95% CI 0.06-0.08) during the pandemic, representing a significant 42% increase (p<0.001). Médecins Sans Frontières health centre consultations and hospital admissions decreased by 38% and 37% respectively.
CONCLUSION
The number of infected people was estimated 67 times higher than the number of reported cases. Participants aged 50 years or more were among the most affected. The mortality survey shows an increase in the mortality rate during the pandemic compared to before the pandemic. A decline in attendance at health facilities was observed and sustained despite the easing of restrictions.
Identifiants
pubmed: 34919545
doi: 10.1371/journal.pone.0260989
pii: PONE-D-21-26784
pmc: PMC8683031
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0260989Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Euro Surveill. 2021 Mar;26(11):
pubmed: 33739254
Int J Infect Dis. 2020 Nov;100:112-116
pubmed: 32891737
PLoS One. 2020 Oct 29;15(10):e0240878
pubmed: 33119621
JAMA. 2021 Oct 12;326(14):1436-1438
pubmed: 34473191
Confl Health. 2020 Jul 31;14:54
pubmed: 32754225
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033172
J Virol Methods. 2021 Apr;290:114067
pubmed: 33476707
Nat Commun. 2021 Jun 15;12(1):3643
pubmed: 34131124
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Clin Infect Dis. 2021 Apr 8;72(7):e192-e195
pubmed: 33161427
Int J Infect Dis. 2021 Jan;102:483-488
pubmed: 33010461
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
PLoS Med. 2020 Jun 16;17(6):e1003144
pubmed: 32544156
J Med Virol. 2021 Apr;93(4):2196-2203
pubmed: 33107601
Int J Infect Dis. 2021 Nov;112:25-34
pubmed: 34481966